Formus
Auckland
About Formus
Formus is enabling personalized orthopedics at scale through a fusion of AI-automation with computational biomechanics. Built on 20 years of musculoskeletal research at the Auckland Bioengineering Institute, Formus 3D pre-op planning is FDA, PMDA, and TGA cleared, and has planned over 3,000 hip replacement surgeries at more than 25 sites across ANZ, Japan, and the US. We are at the next frontier of orthopedics, combining AI-automation with patient-specific modelling of bony and soft-tissue to optimize joint replacement surgeries for each and every patient. Working in tandem with implant manufacturers, we integrate seamlessly into existing industry workflows to reduce costs and vastly increase reliability and scalability. Formus's unique capabilities empower surgeons to revolutionize personalized orthopedics at scale to improve the outcomes of every patient.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.2M
- Funding stage: Seed
- Last round: Grant (Jul 2024)
- Website: formus.com
- Phone: +64 21401085
Industries & Categories
3D Technology, Artificial Intelligence (AI), Machine Learning, Medical Device, SaaS
Social Profiles
Canonical: https://fsome.com/organization/formus-9867 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.